Oxymetholone Tablets and Oral Steroid Products
Oxymetholone Overview
Oxymetholone is a category within oral steroid tablet listings, commonly presented under the compound name Oxymetholone and, in some cases, under the Anadrol brand reference. Across different manufacturers, this category is usually identified by the stated substance, tablet strength, tablet count and brand-specific product name. Because naming conventions vary between labs, careful comparison of the label and full listing details is important when distinguishing one presentation from another.
Within this category, the main points of difference are not broad claims but specification details. Listings may vary by stated strength such as 25 mg or 50 mg, by tablet count such as 50 or 100 tablets, and by manufacturer presentation. The most useful approach is to compare the exact compound name, the printed strength per tablet, the pack format and the manufacturer or brand reference shown on the packaging and listing.
What to Compare
Oxymetholone listings often look similar at first glance, especially where multiple brands use close naming styles such as Anadrol, Androl, Oxy or Oxymetholon. For clear identification, start with the stated compound name. Some products place the brand name first, while others place the compound name first. Where both appear, the listing should make it possible to verify that Oxymetholone is the stated substance and not a different oral steroid category.
The next point to compare is strength per tablet. In this category, verified product names show both 25 mg and 50 mg presentations. This matters for accurate distinction between listings that may otherwise share very similar branding. A product labelled 25 mg should not be treated as equivalent to a 50 mg listing, even if the brand family or packaging style appears close. The strength reference should always be read as the amount stated for each tablet when that is how the listing is presented.
Tablet count is another key comparison point. Verified names in this category include pack counts such as 50 tablets, 60 tablets and 100 tablets. This should be read separately from the strength. For example, a 50 mg 50-tablet presentation and a 25 mg 100-tablet presentation are different formats and should be compared as separate listings rather than as direct equivalents.
Brand and manufacturer identity can also help separate similar items. This category includes references from multiple brands, including Aslan Pharma USA, Beligas Pharma INT, Beligas Pharma USA, Bull Pharma USA, Crowx Labs. USA, Deus Medical, Driada Medical EU, Evolve Biolabs INT, Gomeisa Labs USA, Hemi Pharma UK and Hutech Labs USA. Even where the stated substance is the same, artwork, naming order, pack count and tablet strength may differ between brands.
It is also useful to compare the exact product title format. Some listings include the compound followed by the strength, some include a brand-led title such as Anadromed 50, and some add the tablet count directly into the name. Where several near-identical titles exist, the most reliable identifiers are the stated compound, strength, tablet quantity and manufacturer reference together rather than the short marketing name alone.
- Check whether the listing states Oxymetholone clearly in the title or packaging reference.
- Confirm the strength per tablet, commonly shown as 25 mg or 50 mg in this category.
- Compare tablet quantity separately from strength.
- Review the manufacturer or brand reference for exact identification.
- Use packaging images and listing details together when distinguishing similar products.
Technical Overview
Based on the verified category data, Oxymetholone appears in oral tablet presentations under a range of brand-specific product names. The parent category is Oral Steroids (Steroid Pills), so the primary listing format here is tablet-based rather than other product forms. Because individual brands present the compound differently, a technical overview is helpful when checking whether two listings are actually the same specification.
- Category name
- Oxymetholone
- Parent category
- Oral Steroids (Steroid Pills)
- Common alternate reference in listings
- Anadrol
- Listed product form
- Tablets
- Verified strengths seen in category product names
- 25 mg and 50 mg presentations
- Verified pack counts seen in category product names
- 50 tablets, 60 tablets and 100 tablets
- Brand presentation style
- Compound-led and brand-led naming formats both appear
- Comparison focus
- Stated substance, strength per tablet, tablet count and manufacturer reference
Examples from the verified data show how varied category naming can be. Listings include titles such as Anadrol 25, Anadrol 50, Anadromed 50, Oxymetholon 50, Oxybull 50, Oxyrow 50 mg 100 Tabs and Oxymetholone 25mg/tab. This means that the same compound may appear under several different naming structures. When comparing products, it is more accurate to rely on the specification details than on shorthand naming alone.
Where a listing includes both a strength and a tablet count, those details help establish the exact presentation. For example, 25 mg 100 tablets and 50 mg 50 tablets are different references. If a title is abbreviated, the packaging image or full listing text should be checked for confirmation of the complete specification.
Safety and Verification
For this category, the most important safety-related step is accurate product verification. Check that the compound name on the listing matches the packaging, and confirm that the strength and tablet count shown in the title are also reflected on the pack. If the manufacturer provides a batch reference, serial marking or other printed identifier on the packaging, retain the packaging for verification purposes.
It is also sensible to compare the listing against known brand naming patterns. Some manufacturers consistently use a house style such as a short brand-led title plus the strength, while others print the full compound name more prominently. Differences in spelling such as Oxymetholone and Oxymetholon may reflect brand presentation rather than a different category, but the stated substance and manufacturer details should still be checked carefully.
Only specification-led comparison should guide identification. Avoid relying on informal nicknames or community shorthand when verifying a product reference. These terms can overlap with brand references and do not always provide enough detail to distinguish between strengths, tablet counts or manufacturers.
Store according to the information printed on the original packaging. Keep the packaging available for checking batch, brand and specification details if verification is needed later.
Popular Compounds
Featured Brands
- Aslan Pharma USA
- Beligas Pharma INT
- Beligas Pharma USA
- Bull Pharma USA
- Crowx Labs. USA
- Deus Medical
- Driada Medical EU
- Evolve Biolabs INT
- Gomeisa Labs USA
- Hemi Pharma UK
- Hilma Biocare EU
- Hutech Labs USA
Frequently Asked Questions
- Is Oxymetholone the same as Anadrol?
- Anadrol is a well-known brand reference associated with Oxymetholone in some listings. The clearest way to confirm a match is to check whether Oxymetholone is stated on the listing or packaging.
- What strengths appear in this category?
- Based on the verified product names provided, 25 mg and 50 mg tablet presentations appear in this category.
- Are all Oxymetholone listings packaged the same way?
- No. Brand naming, artwork, tablet count and presentation can vary between manufacturers even when the stated substance is the same.
- Why is tablet count important when comparing listings?
- Tablet count helps distinguish between different pack formats. It should always be checked separately from the strength per tablet.
- What details are most useful for verification?
- The most useful details are the stated substance, strength per tablet, tablet quantity, brand name and any batch or pack reference shown on the original packaging.
- How should this category be stored?
- Store according to the information printed on the original packaging and retain the packaging for identification and verification purposes.




























